Status:
NOT_YET_RECRUITING
Speech Motor Learning and Retention (Aim 3)
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Speech
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
The overall goal of this research is to test a new model of speech motor learning, whose central hypothesis is that learning and retention are associated with plasticity not only in motor areas of the...
Detailed Description
The focus of this registration is Aim 3. Excitability will be assessed. In Aim 3, resting-state fMRI will be interleaved with speech motor adaptation, again using Harvard Sentences. Additional scans a...
Eligibility Criteria
Inclusion
- Fluent English speakers
- Right-handed
- Normal hearing
- No speech disorder or reading disability
Exclusion
- Cardiac pacemaker
- Aneurysm clip
- Heart or Vascular clip
- Prosthetic valve
- Metal implants
- Metal in brain, skull, or spinal cord
- Implanted neurostimulator
- Medication infusion device
- Cochlear implant or tinnitus (ringing in ears)
- Personal and/or family history of epilepsy or other neurological disorders or history of head concussion
- Psychoactive medications
- Pregnancy
Key Trial Info
Start Date :
February 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2029
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06492252
Start Date
February 1 2026
End Date
May 31 2029
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale Child Study Center
New Haven, Connecticut, United States, 06520